In our robust regression model, denosumab use showed a trend toward growth suppression, consistent with its known clinical effects; however, this did not eliminate the positive signal of PD-L1 (Supplementary Table 2), indicating that both pathways may contribute distinctively to growth kinetics.
← all excerpts
PD-L1 mRNA expression correlates with tumor growth rate in giant cell tumor of bone: a volumetric MRI analysis.
1
—
—